96 related articles for article (PubMed ID: 32615661)
21. Identification of polcalcin as a novel allergen of Amaranthus retroflexus pollen.
Vakili Moghaddam M; Fallahpour M; Mohammadi M; Rasi Varaee FS; Mokhtarian K; Khoshmirsafa M; Jafari R; Shirzad N; Falak R
Allergol Immunopathol (Madr); 2019; 47(4):357-364. PubMed ID: 30770138
[TBL] [Abstract][Full Text] [Related]
22. Generation of an allergy vaccine by disruption of the three-dimensional structure of the cross-reactive calcium-binding allergen, Phl p 7.
Westritschnig K; Focke M; Verdino P; Goessler W; Keller W; Twardosz A; Mari A; Horak F; Wiedermann U; Hartl A; Thalhamer J; Sperr WR; Valent P; Valenta R
J Immunol; 2004 May; 172(9):5684-92. PubMed ID: 15100313
[TBL] [Abstract][Full Text] [Related]
23. A hypoallergenic vaccine obtained by tail-to-head restructuring of timothy grass pollen profilin, Phl p 12, for the treatment of cross-sensitization to profilin.
Westritschnig K; Linhart B; Focke-Tejkl M; Pavkov T; Keller W; Ball T; Mari A; Hartl A; Stöcklinger A; Scheiblhofer S; Thalhamer J; Ferreira F; Vieths S; Vogel L; Böhm A; Valent P; Valenta R
J Immunol; 2007 Dec; 179(11):7624-34. PubMed ID: 18025208
[TBL] [Abstract][Full Text] [Related]
24. Constructing a hybrid molecule with low capacity of IgE binding from Chenopodium album pollen allergens.
Nouri HR; Varasteh A; Vahedi F; Chamani J; Afsharzadeh D; Sankian M
Immunol Lett; 2012 May; 144(1-2):67-77. PubMed ID: 22504204
[TBL] [Abstract][Full Text] [Related]
25. Profilin (Che a 2) and polcalcin (Che a 3) are relevant allergens of Chenopodium album pollen: isolation, amino acid sequences, and immunologic properties.
Barderas R; Villalba M; Pascual CY; Batanero E; Rodríguez R
J Allergy Clin Immunol; 2004 Jun; 113(6):1192-8. PubMed ID: 15208604
[TBL] [Abstract][Full Text] [Related]
26. Specific panallergen peptide of Sorghum Polcalcin showing IgE response identified based on in silico and in vivo peptide mapping.
Bokka CS; Veeramachaneni GK; Thunuguntla VBSC; Manda NK; Bondili JS
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31694050
[TBL] [Abstract][Full Text] [Related]
27. Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen.
Hochreiter R; Stepanoska T; Ferreira F; Valenta R; Vrtala S; Thalhamer J; Hartl A
Eur J Immunol; 2003 Jun; 33(6):1667-76. PubMed ID: 12778485
[TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of Che a 1 allergen from Chenopodium album pollen.
Barderas R; Villalba M; Lombardero M; Rodríguez R
Int Arch Allergy Immunol; 2002 Jan; 127(1):47-54. PubMed ID: 11893853
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic potential of peptides from Ole e 1 in olive-pollen allergy.
Calzada D; Cremades-Jimeno L; Pedro MÁ; Baos S; Rial M; Sastre J; Quiralte J; Florido F; Lahoz C; Cárdaba B
Sci Rep; 2019 Nov; 9(1):15942. PubMed ID: 31685862
[TBL] [Abstract][Full Text] [Related]
30. Engineered recombinant ovomucoid third domain can modulate allergenic response in Balb/c mice model.
Rupa P; Mine Y
Biochem Biophys Res Commun; 2006 Apr; 342(3):710-7. PubMed ID: 16494843
[TBL] [Abstract][Full Text] [Related]
31. IgE Reactivity to Polcalcins Varies According to Pollen Source.
Asero R; Mistrello G; Amato S
J Investig Allergol Clin Immunol; 2016; 26(6):362-365. PubMed ID: 27996942
[TBL] [Abstract][Full Text] [Related]
32. IgE-blocking antibodies following SLIT with recombinant Mal d 1 accord with improved apple allergy.
Sánchez Acosta G; Kinaciyan T; Kitzmüller C; Möbs C; Pfützner W; Bohle B
J Allergy Clin Immunol; 2020 Oct; 146(4):894-900.e2. PubMed ID: 32259540
[TBL] [Abstract][Full Text] [Related]
33. Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1.
Mahler V; Vrtala S; Kuss O; Diepgen TL; Suck R; Cromwell O; Fiebig H; Hartl A; Thalhamer J; Schuler G; Kraft D; Valenta R
Clin Exp Allergy; 2004 Jan; 34(1):115-22. PubMed ID: 14720271
[TBL] [Abstract][Full Text] [Related]
34. Hypoallergenic mutants of Ole e 1, the major olive pollen allergen, as candidates for allergy vaccines.
Marazuela EG; Rodríguez R; Barber D; Villalba M; Batanero E
Clin Exp Allergy; 2007 Feb; 37(2):251-60. PubMed ID: 17250698
[TBL] [Abstract][Full Text] [Related]
35. Phl p 1-specific human monoclonal IgE and design of a hypoallergenic group 1 grass pollen allergen fragment.
Levin M; Rydnert F; Källström E; Tan LW; Wormald PJ; Lindstedt M; Greiff L; Ohlin M
J Immunol; 2013 Jul; 191(2):551-60. PubMed ID: 23761636
[TBL] [Abstract][Full Text] [Related]
36. Interplay between Affinity and Valency in Effector Cell Degranulation: A Model System with Polcalcin Allergens and Human Patient-Derived IgE Antibodies.
Bucaite G; Kang-Pettinger T; Moreira J; Gould HJ; James LK; Sutton BJ; McDonnell JM
J Immunol; 2019 Oct; 203(7):1693-1700. PubMed ID: 31462504
[TBL] [Abstract][Full Text] [Related]
37. Enhanced diagnosis of pollen allergy using specific immunoglobulin E determination to detect major allergens and panallergens.
Orovitg A; Guardia P; Barber D; de la Torre F; Rodríguez R; Villalba M; Salcedo G; Monteseirìn J; Conde J
J Investig Allergol Clin Immunol; 2011; 21(4):253-9. PubMed ID: 21721370
[TBL] [Abstract][Full Text] [Related]
38. Disruption of allergenic activity of the major grass pollen allergen Phl p 2 by reassembly as a mosaic protein.
Mothes-Luksch N; Stumvoll S; Linhart B; Focke M; Krauth MT; Hauswirth A; Valent P; Verdino P; Pavkov T; Keller W; Grote M; Valenta R
J Immunol; 2008 Oct; 181(7):4864-73. PubMed ID: 18802090
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of Th2 immune responses by sublingual administration of poly (lactic-co-glycolic) acid (PLGA)-encapsulated allergen in BALB/c mice.
Salari F; Varasteh AR; Vahedi F; Hashemi M; Sankian M
Int Immunopharmacol; 2015 Dec; 29(2):672-678. PubMed ID: 26404189
[TBL] [Abstract][Full Text] [Related]
40. The recombinant major allergen of Parietaria judaica and its hypoallergenic variant: in vivo evaluation in a murine model of allergic sensitization.
Orlandi A; Grasso F; Corinti S; Marinaro M; Bonura A; Boirivant M; Colombo P; Di Felice G
Clin Exp Allergy; 2004 Mar; 34(3):470-7. PubMed ID: 15005743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
